These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 19574598)

  • 1. More on pharmacogenomics and warfarin.
    Anderson DC
    Am J Health Syst Pharm; 2009 Jul; 66(14):1256-7. PubMed ID: 19574598
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacogenomics and warfarin.
    Anderson DC
    Am J Health Syst Pharm; 2009 Jan; 66(2):121. PubMed ID: 19139475
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacogenomics and personalized medicine in clinical practice.
    Manolopoulos VG; Dechairo B; Huriez A; Kühn A; Llerena A; van Schaik RH; Yeo KT; Ragia G; Siest G
    Pharmacogenomics; 2011 May; 12(5):597-610. PubMed ID: 21619425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacogenomics: opportunities and challenges at point of care.
    Scott SA
    Clin Pharmacol Ther; 2013 Jan; 93(1):33-5. PubMed ID: 23212102
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacogenomics of warfarin: uncovering a piece of the warfarin mystery.
    Gulseth MP; Grice GR; Dager WE
    Am J Health Syst Pharm; 2009 Jan; 66(2):123-33. PubMed ID: 19139476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics in hemostasis: friend or foe?
    Rumilla K; Chen D; Baudhuin LM
    Semin Thromb Hemost; 2009 Feb; 35(1):42-9. PubMed ID: 19308892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenomics in psychiatry: clinical issues to be considered.
    Licinio J; Wong ML
    Mol Psychiatry; 2005 Jul; 10(7):615. PubMed ID: 15976808
    [No Abstract]   [Full Text] [Related]  

  • 8. Special Section on Pharmacogenomics: recent advances and future directions.
    Mushiroda T; Giacomini KM; Kubo M
    J Hum Genet; 2013 Jun; 58(6):305. PubMed ID: 23797326
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical implications of pharmacogenomics for tardive dyskinesia.
    Müller DJ; Shinkai T; De Luca V; Kennedy JL
    Pharmacogenomics J; 2004; 4(2):77-87. PubMed ID: 15042144
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacogenetics in cardiovascular disorders: an update on the principal drugs.
    Predazzi IM; Mango R; Norata GD; Di Daniele N; Sergi D; Romeo F; Novelli G
    Am J Cardiovasc Drugs; 2013 Apr; 13(2):79-85. PubMed ID: 23539170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Descriptive analysis of clinical trials with pharmacogenetics substudy submitted to the Ethics Committee of Andalusia, Spain (2005-2008)].
    Alanís López J; Fernández López JA; Carretero Guerra R; Durán Quintana JA
    Med Clin (Barc); 2012 Oct; 139(8):354-7. PubMed ID: 22795663
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacogenetics: The right drug for you.
    Drew L
    Nature; 2016 Sep; 537(7619):S60-2. PubMed ID: 27602742
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacogenomics and the management of oral anticoagulation.
    Wittkowsky AK
    Curr Hematol Rep; 2004 Sep; 3(5):363-7. PubMed ID: 15341704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetics testing: implications for cardiovascular therapeutics with clopidogrel and warfarin.
    George J; Doney A; Palmer CN; Lang CC
    Cardiovasc Ther; 2010 Jun; 28(3):135-8. PubMed ID: 20557312
    [No Abstract]   [Full Text] [Related]  

  • 15. Raju Kucherlapati talks about personalised medicine: breathing new life into old drugs. Interview by Steve Carney.
    Kucherlapati R
    Drug Discov Today; 2007 Apr; 12(7-8):272-5. PubMed ID: 17458021
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacogenomics and pharmacogenetics. 1st Spanish Congress on Pharmacogenomics and Pharmacogenetics, January 23-25, 2005, Valencia, Spain.
    Iqbal O
    Pharmacogenomics; 2005 Apr; 6(3):205-7. PubMed ID: 16013951
    [No Abstract]   [Full Text] [Related]  

  • 17. Meta-analysis of efficacy and safety of genotype-guided pharmacogenetic dosing of warfarin.
    Xu H; Xie X; Wang B; Chen Y; Meng T; Ma S; Wang F
    Int J Cardiol; 2014 Dec; 177(2):654-7. PubMed ID: 25449474
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical Trial Designs to Support Clinical Utility of Pharmacogenomic Testing.
    Drozda K; Pacanowski MA
    Pharmacotherapy; 2017 Sep; 37(9):1000-1004. PubMed ID: 28605049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Personalized medicine prompts push to redesign clinical trials.
    Singer E
    Nat Med; 2005 May; 11(5):462. PubMed ID: 15875041
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacogenomics: paving the path to personalized medicine.
    Patrinos GP; Innocenti F
    Pharmacogenomics; 2010 Feb; 11(2):141-6. PubMed ID: 20136354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.